search

Active clinical trials for "Hypertension"

Results 2441-2450 of 5863

Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension...

Essential Hypertension

Children are increasingly being diagnosed with essential hypertension and the absence of comparative effectiveness research in antihypertensive therapies has contributed to considerable differences in prescribing practices among physicians treating children with essential hypertension. This study will consist of a series of systematically-administered n-of-1 trials among children to verify the need for ongoing antihypertensive treatment and if so, to identify the preferred single drug therapy.

Completed4 enrollment criteria

Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled...

Hypertension

To evaluate antihypertensive efficacy and tolerability of Nifedipine GITS 60mg treated for 8 weeks in Chinese hypertensive subjects who failed to achieve BP control with the starting-dose antihypertensive monotherapy.

Completed20 enrollment criteria

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in...

Essential Hypertension

Compare the safety and efficacy of amlodipine besylate and candesartan cilexetil combination therapy on patients of essential hypertension who are not properly controlled by candesartan cilexetil monotherapy.

Completed30 enrollment criteria

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in...

Essential Hypertension

Compare the safety and efficacy of amlodipine besylate and candesartan cilexetil combination therapy on patients of essential hypertension who are not properly controlled by amlodipine besylate monotherapy.

Completed30 enrollment criteria

Dose-Ranging Study of the Bimatoprost Ocular Insert

Primary Open-Angle GlaucomaOcular Hypertension

The Bimatoprost Ocular Insert is intended to provide sustained delivery of bimatoprost to the ocular surface to lower the intraocular pressure (IOP) in patients with Open-Angle Glaucoma or Ocular Hypertension. This study evaluated the safety and efficacy of two different doses of the Bimatoprost Ocular Insert, compared to an active control arm with timolol ophthalmic solution (0.5%).

Completed26 enrollment criteria

Economic Evaluation of Baroreceptor STIMulation for the Treatment of Resistant HyperTensioN

Hypertension

Medico-economics assessment (cost-effectiveness) of the unilateral carotid barostimulation with Barostim NeoTM compared to usual care in patients with resistant hypertension (multicenter randomized, PROBE trial), followed-up for 12 months, with a lifetime-long modeling.

Completed16 enrollment criteria

Isometric Handgrip Exercise for Blood Pressure Management

Hypertension

Recent meta-analyses suggest isometric resistance training (IRT) may be superior to aerobic exercise for lowering blood pressure. The investigators intend to conduct the largest, longest, prospective, double-blind randomized controlled trial using isometric resistance training to reduce blood pressure to reduce hypertension.

Completed15 enrollment criteria

Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential...

HypertensionEssential

Fimasartan (FMS) is an AT1 receptor antagonist indicated for once a day administration, currently approved for the treatment of essential hypertension in Corea and Mexico. As the safety and efficacy of FMS was initially demonstrated in Korea only, it was necessary to address the potential for ethnic factors to have an effect on the drug´s efficacy and safety in the Mexican population. To address this need, a cohort of 272 Mexican subjects with grades 1-2 essential hypertension were sequentially treated on a treat to target basis (target: sitting Diastolic Blood Pressure (sDBP) <90 mmHg) with 60 mg FMS once a day (8 weeks), either 120 mg FMS or 60 mg FMS+12.5 mg HCTZ once a day (randomized 4 week treatment period) and 120 mg FMS once a day (during 12 weeks) for a total treatment period of 24 weeks.

Completed21 enrollment criteria

Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B

Hypertension

The purpose of this study is to compare the safety and pharmacokinetics of CKD-330 (fixed-dose combination of Candesartan 16 mg and Amlodipine 5 mg) with coadministration of the two separate drugs in healthy male volunteers.

Completed21 enrollment criteria

Pulmonary Hypertension and Anastrozole Trial

Pulmonary Arterial Hypertension

The primary objectives of this study are to determine whether the study drug, anastrozole may improve six minute walk distance at six months compared to placebo and to assess safety and side effects up to twelve months in pulmonary arterial hypertension (PAH).

Completed23 enrollment criteria
1...244245246...587

Need Help? Contact our team!


We'll reach out to this number within 24 hrs